Cencora falls after Q2 results miss estimates

Cencora

06/05/2026 16:01

Updates

** Shares of drug distributor Cencora COR.N fall 17.5% to over one-year low of $252.21

** Q2 revenue of $78.4 billion misses estimates of $81.09 billion, according to LSEG data

** Q2 adj. EPS of $4.75 comes below estimates of $4.81

** Co raises annual profit per share outlook to be between $17.65 and $17.90 from $17.45 to $17.75 expected previously

** Stock down ~26% YTD

 (Reporting by Sriparna Roy in Bengaluru)

 ((Sriparna.Roy@thomsonreuters.com;))